Alto Neuroscience : ANRO

ANRO

Stock Data

$24.94

$0.72 (2.81%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Alto Neuroscience Inc is a pioneering biopharmaceutical company focused on developing innovative treatments for mental health conditions such as major depressive disorder (MDD), post-traumatic stress disorder, cognitive impairments associated with schizophrenia, and more. With a robust pipeline including ALTO-100, ALTO-300, ALTO-101, ALTO-203, and ALTO-202, Alto Neuroscience leverages cutting-edge science and an AI-enabled biomarker platform to tailor therapies to individual patient needs. Founded in 2019 and based in Los Altos, California, the company is at the forefront of addressing unmet needs in psychiatric medicine.